As the global population ages at an unprecedented rate, the demand for innovative medical therapies is set to surge, challenging industries to adapt. By 2030, one in six people will...
The pharmaceutical industry stands at a crossroads as governments worldwide push for dramatic prescription drug price cuts. With major legislation like the Inflation Reduction Act targeting cost reductions, even the...
Iris Energy's ambitious expansion into the Sweetwater data centre and AI sector comes with pressing financial challenges. With just $200 million on hand against a multi-billion-dollar project, the risk of...
Karyopharm Therapeutics offers a tantalising investment prospect with its lead product, XPOVIO. Promising Phase 2 results in myelofibrosis signal untapped potential, while a significant market opportunity and undervaluation suggest robust...
Google's AI workloads have soared dramatically, with inference tokens skyrocketing from 71 trillion to 634 trillion in less than a year. This astonishing growth signals a transformative shift in AI...
Iris Energy's ambitious Sweetwater project in Texas presents a staggering $70 billion funding challenge against a mere $200 million cash reserve. As they pivot towards AI and HPC infrastructure alongside...
Significant buying activity in SoFi Technologies has raised eyebrows, with recent acquisitions at mid-17 levels contrasting sharply with prior sell-offs at lower prices. This shift suggests a potential inflection point...
In an eye-catching manoeuvre, Jeff Bezos has offloaded more than $5.4 billion in Amazon shares at $217.12 each. This sizable transaction raises questions about its timing, as it occurs amidst...
Alphabet is stealthily establishing itself as a formidable force in AI infrastructure, leveraging its proprietary Tensor Processing Units (TPUs) to generate 70% of its compute capacity. This move comes as...
A significant investment of roughly 2 million shares in SoFi Technologies for a flagship innovation fund signals renewed confidence in the fintech sector. With a 40% year-on-year revenue growth and...
